Invest
Substance abuse, mental health and the ‘staggering’ economic impact
Fresh research on brain disorders in Australia has revealed the scale and cost of substance abuse, mental health and neurological conditions on the national economy.
Substance abuse, mental health and the ‘staggering’ economic impact
Fresh research on brain disorders in Australia has revealed the scale and cost of substance abuse, mental health and neurological conditions on the national economy.
A new whitepaper, Review of the burden of disease for neurological, mental health and substance use disorders in Australia, has been commissioned by Mindgardens Neuroscience Network and KPMG to determine the impact such disorders have on the Australian economy.
From a cost perspective, the whitepaper found neurological, mental health and substance abuse disorders are costing the Australian economy in excess of $74 billion.
Breaking it down, the research revealed mental health disorders and suicide are costing the nation over $33 billion each year, while neurological disorders are costing over $31 billion, and substance use disorders are costing almost $10 billion.
The scale of the disorders was also highlighted, with the whitepaper determining brain disorders now account for 20.5 per cent of the total burden of disease in Australia.
From 2010 to 2017, it noted substance abuse disorders grew by 24.7 per cent, followed by neurological disorders at 15.6 per cent, and mental health disorders by 8.6 per cent.
The largest “burden of disease” is exhibited by opioid use disorders, major depressive and anxiety disorders, stroke and Alzheimer’s/dementia disorders, according to the research.
“Relative to cancer and cardiovascular disease, these disorders do not receive overall research investment commensurate with the burden they impose on the community,” it noted.
Commenting on the findings, Professor Peter Schofield, interim co-CEO of Mindgardens, expressed the need for a stronger response to the statistics surrounding brain disorders.
“Our national research agenda should align to better incorporate and prioritise these disorders and build the specific research capability to address them into the future,” Mr Schofield said.
“Our whitepaper also investigates the potential return on investment for already validated health interventions and indicates a number which, if adopted, would cost-effectively improve health outcomes.
“These include online mental health programs, which are highly effective in treating depression and anxiety. However, the infrastructure to put these treatments into action is weak, so we need to establish an e-mental health infrastructure and shared industry/health models that could then be used to expand these cost-effective health interventions to treat and prevent these and other brain disorders.”
Stock market
Beware the reversal of the share market rally, expert says
The companies that offer the greatest risk for investors in 2021 are somewhat ironically many of the same companies that have provided the greatest return to investors in 2020, an expert has warned ...Read more
Stock market
Is climate change the next big investment theme?
Investors looking to outperform the market are being urged to look at structural growth, with climate change likely to create the biggest investment opportunity since the internet, an industry expert ...Read more
Stock market
All Ords set for new record by February, analyst predicts
The Australian market is likely to reach a new record in the early months of the year, with a win on the health front likely to offset geopolitical issues, an analyst has stated. ...Read more
Stock market
Aussies flock to fixed interest and ETP products for stable returns
Investors seeking stability during the COVID-19 pandemic have turned to fixed interest and cash exchange-traded products, new research has revealed. ...Read more
Stock market
Emerging market equities gain traction in post-pandemic world
Emerging market equities are making a comeback as technology-savvy consumers flock to capitalise on new opportunities that the 2020 pandemic may have made too attractive to ignore. ...Read more
Stock market
Is it too late to start investing in market index ETFs?
With the Australian market recovering its losses since the pandemic began, nestegg asked an industry expert if it was too late for investors to begin their investing journey. ...Read more
Stock market
Is it time to buy reopening stocks?
Investors are being advised to look into stocks that could benefit from markets reopening, an analyst has stated. ...Read more
Stock market
Stocks to watch in 2021
Easing political uncertainty, new vaccine hopes, central bank’s willingness to do all it takes and more, and new stimulus packages are likely to act as tailwinds for investors, an analyst has said. ...Read more
Stock market
Beware the reversal of the share market rally, expert says
The companies that offer the greatest risk for investors in 2021 are somewhat ironically many of the same companies that have provided the greatest return to investors in 2020, an expert has warned ...Read more
Stock market
Is climate change the next big investment theme?
Investors looking to outperform the market are being urged to look at structural growth, with climate change likely to create the biggest investment opportunity since the internet, an industry expert ...Read more
Stock market
All Ords set for new record by February, analyst predicts
The Australian market is likely to reach a new record in the early months of the year, with a win on the health front likely to offset geopolitical issues, an analyst has stated. ...Read more
Stock market
Aussies flock to fixed interest and ETP products for stable returns
Investors seeking stability during the COVID-19 pandemic have turned to fixed interest and cash exchange-traded products, new research has revealed. ...Read more
Stock market
Emerging market equities gain traction in post-pandemic world
Emerging market equities are making a comeback as technology-savvy consumers flock to capitalise on new opportunities that the 2020 pandemic may have made too attractive to ignore. ...Read more
Stock market
Is it too late to start investing in market index ETFs?
With the Australian market recovering its losses since the pandemic began, nestegg asked an industry expert if it was too late for investors to begin their investing journey. ...Read more
Stock market
Is it time to buy reopening stocks?
Investors are being advised to look into stocks that could benefit from markets reopening, an analyst has stated. ...Read more
Stock market
Stocks to watch in 2021
Easing political uncertainty, new vaccine hopes, central bank’s willingness to do all it takes and more, and new stimulus packages are likely to act as tailwinds for investors, an analyst has said. ...Read more
More articles
Website Notifications
Get notifications in real-time for staying up to date with content that matters to you.
